ARENA PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ARENA PHARMACEUTICALS INC has filed 1,425 SEC EDGAR filings since 28 Apr 2000

SEC filing history

Showing 651-675 of 822 matching filings.

Per page
25
Current page
27
8-K File 000-31161

FORM 8-K

Filing date
17 May 2012
Reporting date
16 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-181434

PROSPECTUS SUPPLEMENT

Filing date
17 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-181434

PRELIMINARY PROSPECTUS SUPPLEMENT

Filing date
15 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
15 May 2012
Reporting date
15 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-181434

FORM S-3ASR

Filing date
15 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
10 May 2012
Reporting date
09 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
01 May 2012
Reporting date
01 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-31161

AUTO-GENERATED PAPER DOCUMENT

Filing date
30 Apr 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-31161

DEFINITIVE PROXY STATEMENT

Filing date
27 Apr 2012
Reporting date
15 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-160983

PROSPECTUS

Filing date
10 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-167498

PROSPECTUS

Filing date
10 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-31161

PRELIMINARY PROXY STATEMENT

Filing date
09 Apr 2012
Reporting date
15 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Mar 2012
Reporting date
29 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
26 Mar 2012
Reporting date
26 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Mar 2012
Reporting date
19 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Mar 2012
Reporting date
19 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Mar 2012
Reporting date
19 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Mar 2012
Reporting date
19 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Mar 2012
Reporting date
19 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Mar 2012
Reporting date
19 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
14 Mar 2012
Reporting date
14 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-166481

PROSPECTUS SUPPLEMENT

Filing date
08 Mar 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
08 Mar 2012
Reporting date
08 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .